test

Nicholas Boston

@Highvista Strategies Llc

Latest period2024 - Q3ReportedManaged Assets$289.961MTotal holdings142
Assets growth rate5.92%Assets growth rate (2-Q avg)1.78%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Highvista Strategies Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 142 positions.

Assets under management

The assets under management (AUM) of Highvista Strategies Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 289.961M in assets, with a quarterly growth rate of 5.92% and a 2-quarter average growth rate of 1.78%. The portfolio is managed by Nicholas Boston, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
DNTHDianthus Therapeutics Inc
Recent Activity
New Position
0.19%
$542,343
19,808 shares@ $27.38 avg price
CGEMCullinan Therapeutics Inc
Recent Activity
New Position
0.19%
$533,889
31,893 shares@ $16.75 avg price
CYTKCytokinetics Inc
Recent Activity
New Position
0.19%
$530,904
10,055 shares@ $52.8 avg price
ANABAnaptysbio Inc
Recent Activity
New Position
0.18%
$521,729
15,574 shares@ $33.5 avg price
ETNB89bio Inc
Recent Activity
New Position
0.18%
$494,224
66,787 shares@ $7.41 avg price
URGNUrogen Pharma Ltd
Recent Activity
New Position
0.17%
$489,788
38,566 shares@ $12.7 avg price
IRONDisc Medicine Inc
Recent Activity
New Position
0.17%
$470,024
9,565 shares@ $49.14 avg price